Loxo Oncology, Inc. IPO Research Information

Loxo Oncology, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Loxo Oncology, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Loxo Oncology, Inc.	LOXO - NASDAQ	$12.00-$14.00	$13.00	$13.07	5.3 million	8/1/2014
Underwriter(s): Cowen & Co., Stifel
Co-Manager(s): Oppenheimer & Co., JMP Securities
Industry: Health Care
Filing(s): Filed 2014-06-30 Terms Added 2014-07-21

Loxo Oncology, Inc. Quote & Chart - Click for current quote - LOXO

About Loxo Oncology, Inc. (adapted from Loxo Oncology, Inc. prospectus):
They develop targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "LOXO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.